FE65 as a link between VLDLR and APP to regulate their trafficking and processing
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Several studies found that FE65, a cytoplasmic adaptor protein, interacts with APP and LRP1, altering the trafficking and processing of APP. We have previously shown that FE65 interacts with the ApoE receptor, ApoER2, altering its trafficking and processing. Interestingly, it has been shown that FE65 can act as a linker between APP and LRP1 or ApoER2. In the present study, we tested whether FE65 can interact with another ApoE receptor, VLDLR, thereby altering its trafficking and processing, and whether FE65 can serve as a linker between APP and VLDLR. Results: We found that FE65 interacted with VLDLR using GST pull-down and co-immunoprecipitation assays in COS7 cells and in brain lysates. This interaction occurs via the PTB1 domain of FE65. Co-transfection with FE65 and full length VLDLR increased secreted VLDLR (sVLDLR); however, the levels of VLDLR C-terminal fragment (CTF) were undetectable as a result of proteasomal degradation. Additionally, FE65 increased cell surface levels of VLDLR. Moreover, we identified a novel complex between VLDLR and APP, which altered trafficking and processing of both proteins. Furthermore, immunoprecipitation results demonstrated that the presence of FE65 increased the interaction between APP and VLDLR in vitro and in vivo. Conclusions: These data suggest that FE65 can regulate VLDLR trafficking and processing. Additionally, the interaction between VLDLR and APP altered both protein's trafficking and processing. Finally, our data suggest that FE65 serves as a link between VLDLR and APP. This novel interaction adds to a growing body of literature indicating trimeric complexes with various ApoE Receptors and APP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623 · cited 2×
“Additionally, ApoER2, VLDLR, and APP knockout mice exhibit impaired learning and memory and LTP [44-47].”
BackgroundSabo, S. L., Ikin, A. F., Buxbaum, J. D., & Greengard, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.7.1403 · Cited by 237 · cited 3×
“What is the biological significance of this proposed complex? FE65 is known to interact with molecules important in actin remodeling through its WW domains [9], promoting the movement of neuronal growth cones and aiding in cell motility [10].”
BackgroundPietrzik, C. U., Busse, T., Merriam, D. E., Weggen, S., & Koo, E. H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf568 · Cited by 198
Hong, C., Duit, S., Jalonen, P., Out, R., Scheer, L., Sorrentino, V., Boyadjian, R., Rodenburg, K. W., Foley, E., Korhonen, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123729 · Cited by 142 · cited 2×
“To further support our findings, a recent study demonstrated that the E3 ubiquitin Ligase IDOL targets the VLDLR receptor for degradation, specifically through the lysine residues adjacent to the NPXY motif [26].”
BackgroundResultZerbinatti, C. V., Wozniak, D. F., Cirrito, J., Cam, J. A., Osaka, H., Bales, K. R., Zhuo, M., Paul, S. M., Holtzman, D. M., & Bu, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305803101 · Cited by 133
Resveratrol Inhibits Pathologic Retinal Neovascularization in Vldlr−/−Mice
Hua, J., Guerin, K. I., Chen, J., Michán, S., Stahl, A., Krah, N. M., Seaward, M. R., Dennison, R. J., Juan, A. M., Hatton, C. J., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6496 · Cited by 94
Regulation of ApoE receptor proteolysis by ligand binding
Hoe, H.-S., & Rebeck, G. W. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.02.013 · Cited by 85
Self-citationFE65 interaction with the ApoE receptor ApoEr2
Hoe, H.-S., Magill, L. A., Guenette, S., Fu, Z., Vicini, S., & Rebeck, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600728200 · Cited by 69
Self-citationRanganathan, S., Noyes, N. C., Migliorini, M., Winkles, J. A., Battey, F. D., Hyman, B. T., Smith, E., Yepes, M., Mikhailenko, I., & Strickland, D. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5065-10.2011 · Cited by 49 · cited 3×
“We and others have also demonstrated that ApoER2 and APP play an important role in dendritic spine formation [18,29,36,37,48,49].”
BackgroundResult
Cited by
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158
“However, g-secretase cleavage of the CTFs results in the release of the APP Intracellular Domain (AICD), which binds Fe65 and TIP60 for potential transcriptional activation of downstream targets (Cao and Südhof, 2001), ultimately promoting cell death and impairing neurogenesis (Ghosal et al., 2010; Wang et al., 2014).”
Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease
Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121
“Recently, the Fe65-mediated interaction between two further receptors of the LDL receptor gene family and APP, namely megalin (LRP2) and the very-low density lipoprotein receptor, has been reported (Alvira-Botero et al., 2010; Dumanis et al., 2012).”
BackgroundFunctional Roles of the Interaction of APP and Lipoprotein Receptors
Pohlkamp, T., Wasser, C. R., & Herz, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00054 · Cited by 92
“Like Lrp1, the NPxY domain of Apoer2 binds the cytosolic adaptor protein Fe65.”
BackgroundInfluentialSullivan, S. E., Liao, M., Smith, R. V., White, C., Lagomarsino, V. N., Xu, J., Taga, M., Bennett, D. A., De Jager, P. L., & Young-Pearse, T. L. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy376 · Cited by 44
FE65 interacts with ADP-ribosylation factor 6 to promote neurite outgrowth
Cheung, H. N. M., Dunbar, C., Mórotz, G. M., Cheng, W. H., Chan, H. Y. E., Miller, C. C. J., & Lau, K. (2014) · The FASEB Journal · doi:10.1096/fj.13-232694 · Cited by 37
Metadata
- Authors
- Dumanis, S. B., Chamberlain, K. A., Jin Sohn, Y., Jin Lee, Y., Guénette, S. Y., Suzuki, T., Mathews, P. M., Pak, D. T., Rebeck, G. W., Suh, Y.-H., Park, H.-S., & Hoe, H.-S.
- Venue
- Molecular Neurodegeneration
- Published
- 2012-03-19
- Volume
- 7
- Issue
- 1
- Pages
- 9-9
- ISSN
- 1750-1326 (ISSN-L)
- OpenAlex
- W2016291885
- Cited by
- 34
- References
- 11
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FE65 as a link between VLDLR and APP to regulate their trafficking and processing. https://app.cochat.ai/papers/10.1186/1750-1326-7-9
- The paper
- Dumanis, S. B., Chamberlain, K. A., Jin Sohn, Y., Jin Lee, Y., Guénette, S. Y., Suzuki, T., Mathews, P. M., Pak, D. T., Rebeck, G. W., Suh, Y.-H., Park, H.-S., & Hoe, H.-S. (2012). FE65 as a link between VLDLR and APP to regulate their trafficking and processing. Molecular Neurodegeneration. https://doi.org/10.1186/1750-1326-7-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.